This inventor holds 8 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Nhk Engineering System, Inc., Nippon Hoso' Kyokai. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shizuoka, JP (2011 - 2013)
- Kamakura, JP (2022)
- Tokyo, JP (2022 - 2023)
- Kanagawa, JP (2024)
Company Filing History:


Years Active: 2011-2026
Title: The Innovative Mind of Taro Miyazaki: Advancements in Antigen-Binding Molecules
Introduction
Taro Miyazaki, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of immunology and biotechnology. With a total of seven patents to his name, his work focuses on the development of antigen-binding molecules that enhance immune responses against tumors while reducing side effects on normal tissues.
Latest Patents
Among his latest patents is the groundbreaking invention titled "Anti-CD137 Antigen-Binding Molecule and Utilization Thereof." This innovative patent aims to provide anti-CD137 antigen-binding molecules that possess immunocyte-activating effects, cytotoxic activity, and anti-tumor properties. A key feature of this invention is its ability to minimize adverse effects on non-tumor tissues, thereby reducing overall side effects. Miyazaki has also explored the utilization of various substances to enhance binding activity, including small molecule compounds within target tissues. Furthermore, another notable patent involves an antigen-binding molecule with varying activity to CD3 and CD137, which enhances the binding efficacy of antigen-binding domains.
Career Highlights
Taro Miyazaki has held pivotal positions at renowned companies in the pharmaceutical and biotechnology sectors. His experience includes contributions to Chugai Pharmaceutical Co., Ltd. and Japan Broadcasting Corporation (NHK), where he honed his skills in research and development, particularly in the area of immunotherapy and targeted treatment methodologies.
Collaborations
Throughout his career, Miyazaki has collaborated with distinguished professionals in his field, including Tetsuo Kojima and Shun Shimizu. These partnerships have further advanced the research and applications of antigen-binding molecules, showcasing a commitment to collective innovation in biomedicine.
Conclusion
Taro Miyazaki's inventive spirit and commitment to the field of biotechnology underscore his role as a leading figure in the development of effective cancer treatments. His patents stand as a testament to his innovative approach, aiming to improve therapeutic outcomes while minimizing side effects. As biotechnology continues to evolve, contributions from inventors like Miyazaki will undoubtedly play a crucial role in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile